ClinicalTrials.gg
Not yet recruitingNCT07410754SSC-CSUpdated Feb 13, 2026

Effect of Combined Skin-to-Skin Contact and Kangaroo Care on Breastfeeding and Bonding in Cesarean-Born Newborns

An interventional study of Intervention in Breastfeeding, Skin to Skin Contact and Cesarean Birth, sponsored by Istanbul University - Cerrahpasa. Not yet recruiting at 1 site in Turkey (Türkiye). Per ClinicalTrials.gov, last updated 2026-02-13.

Sponsored by Istanbul University - Cerrahpasa · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 16 studies in Breast Feeding by Istanbul University - Cerrahpasa — 8 open to participants now, 8 under way, none of them phase 3. Breast Feeding · Istanbul University - Cerrahpasa.

Planned enrollment
12th of 15
60 · median 100
Started
2026
with 5 others
No phase
15 of 16
7 open now
Registered
12th of 16
by date

Among the 16 studies in Breast Feeding by Istanbul University - Cerrahpasa, this one is the 12th largest by planned enrollment of the 15 interventional ones that give a count, is one of 6 that started in 2026, is one of 15 with no phase, and was the 12th registered.

Breast Feeding

1,083 studies on the registry are indexed under Breast Feeding; 216 are open to participants now.

Browse Breast Feeding studies →

Open to participants now

8 of the 16 studies in Breast Feeding by Istanbul University - Cerrahpasa are open now, in 1 country. Recruiting first, the newest first:

2 more — sign in →

By country, each count listing its studies:

All 8 open studies →

Where they have run

Who these studies take

Of the 125 Breast Feeding studies recruiting now, 65 (52%) set no upper age limit and 58 (46%) stop at 75 or younger; 52 take children under 18; 75 take healthy volunteers.

This study: all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 16 studies in Breast Feeding by Istanbul University - Cerrahpasa, or all of them as a file.
02

Study summary

This randomized controlled study aims to evaluate the effect of consecutive skin-to-skin contact applied by the mother and father on breastfeeding parameters and parent-infant bonding in babies born by cesarean section. The study includes two groups: an intervention group receiving consecutive skin-to-skin contact by the father followed by the mother, and a control group receiving routine postnatal care. Breastfeeding success and parental bonding will be assessed using validated measurement tools during the early postnatal period and follow-up.

Read the detailed description

The global increase in cesarean section rates has become a significant public health concern. In Türkiye, the cesarean section rate reached 57.4% in 2023, one of the highest among OECD countries. Babies born by cesarean section are often deprived of early skin-to-skin contact in the immediate postnatal period due to maternal physical limitations, which may negatively affect breastfeeding outcomes and parent-infant bonding.

Skin-to-skin contact and kangaroo care are evidence-based practices known to support neonatal physiological stability, breastfeeding success, pain management, and parent-infant bonding. However, operational and clinical barriers following cesarean delivery often limit the early implementation of maternal skin-to-skin contact. While the effects of skin-to-skin contact have been extensively studied in the context of mother-infant dyads, evidence regarding father-infant skin-to-skin contact remains limited, particularly in term infants.

Delayed maternal contact following cesarean delivery may result in missed opportunities for early bonding and breastfeeding initiation. In this context, involving fathers in early skin-to-skin contact may provide an effective strategy to compensate for delayed maternal contact. Active paternal participation in newborn care has been shown to support infant development, enhance paternal role adaptation, and strengthen family bonding.

This randomized controlled study will be conducted in the delivery and postpartum units of a private mother- and baby-friendly hospital in Istanbul, Türkiye. The study population will consist of mothers and term newborns born by cesarean section who meet the inclusion criteria. Sample size will be determined using G*Power software.

Participants will be randomly assigned to one of two groups. In the intervention group, newborns will receive uninterrupted skin-to-skin contact with the father for 30 minutes immediately after birth. Painful procedures, including hepatitis B vaccination and vitamin K administration, will be performed during father-infant skin-to-skin contact. Following maternal recovery and confirmation of clinical suitability, consecutive skin-to-skin contact will be initiated between the mother and the newborn. The first breastfeeding attempt will occur during maternal skin-to-skin contact.

The control group will receive routine postnatal care according to the hospital's standard protocol.

Breastfeeding success will be assessed using the Bristol Breastfeeding Assessment Tool prior to discharge, on postpartum day 2, and at one month postpartum. Maternal and paternal bonding will be evaluated using the Maternal Postnatal Attachment Scale (MPAS) and the Paternal Postnatal Attachment Scale (PPAS) at the same time points. Breastfeeding parameters and parental bonding outcomes will be statistically compared between the two groups.

03

Conditions studied

  • Breastfeeding
  • Skin to Skin Contact
  • Cesarean Birth
  • Kangaroo Care

Browse trials for

Keywords

  • Skin-to-Skin Contact
  • Cesarean Birth
  • Breastfeeding Outcomes
  • Maternal Attachment
  • Paternal Attachment
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Mothers who delivered by cesarean section
  • Mothers and fathers willing to participate and provide written
  • Newborns who are stable after birth
  • No health conditions in mothers or fathers that would prevent participation in skin-to-skin contact

Exclusion criteria

Exclusion criteria:

  • Serious maternal or neonatal illness
  • Newborns requiring NICU admission
  • Mothers or fathers unwilling to participate
  • Any maternal or paternal condition preventing the implementation of skin-to-skin contact

Additional note:

-Eligibility is based on biological sex (female for mothers, male for fathers, newborns of any sex), not on gender identity.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Consecutive Skin-to-Skin Contact Group ( İntervention )

    Newborns in this group receive consecutive skin-to-skin contact, first applied by the father for 30 minutes immediately after cesarean delivery, followed by skin-to-skin contact with the mother as soon as maternal clinical condition allows. Routine newborn care is provided alongside the intervention.

    Behavioral: Intervention

  • No intervention
    Routine Care Group ( Control )

    Newborns in this group receive routine postpartum and newborn care according to the hospital's standard clinical protocol following cesarean delivery.

Interventions

  • BehavioralIntervention

    Consecutive skin-to-skin contact is applied to newborns born by cesarean section, first by the father for 30 minutes immediately after birth, followed by skin-to-skin contact with the mother as soon as maternal clinical condition allows. Routine newborn care is provided alongside the intervention.

06

What researchers measure

Primary outcomes

  1. Maternal Postnatal Attachment Scale (MPAS)

    Maternal-infant attachment will be measured using the Maternal Postnatal Attachment Scale (MPAS). This 19-item Likert-type self-report scale assesses the mother's emotions and thoughts toward her infant.

    Time frame: 3 months

Secondary outcomes

  1. Paternal Postnatal Attachment Scale (PPAS)

    Paternal-infant attachment will be measured using the Paternal Postnatal Attachment Scale (PPAS). This 19-item scale evaluates the father's emotional approach, involvement, and interaction with the infant.

    Time frame: 3 months

Other outcomes

  1. Bristol Breastfeeding Assessment Tool (BBAT)

    Breastfeeding success will be assessed using the Bristol Breastfeeding Assessment Tool (BBAT). The tool evaluates mother-infant interaction during breastfeeding, infant positioning, latch, and sucking effectiveness, providing a systematic score of breastfeeding performance.

    Time frame: 3 months

07

Study locations

1 site
  • Zeytinburnu Avrasya Hospitol
    Istanbul, Istanbul, Turkey (Türkiye)
08

References and documents

Publications

  • Martinez-Hortelano JA, Saz-Lara A, Gonzalez JLG, Cristobal-Aguado S, Iglesias-Rus L, Martinez-Vizcaino V, Garrido-Miguel M. Skin-to-skin contact and breastfeeding after caesarean section: A systematic review and meta-analysis of intervention studies. Int J Nurs Stud. 2025 Jun;166:105038. doi: 10.1016/j.ijnurstu.2025.105038. Epub 2025 Mar 5. PubMed 40086104 ↗
  • Abiha U, Banerjee DS, Mandal S. Demystifying non-invasive approaches for screening jaundice in low resource settings: a review. Front Pediatr. 2023 Nov 20;11:1292678. doi: 10.3389/fped.2023.1292678. eCollection 2023. PubMed 38054187 ↗
  • Moore ER, Brimdyr K, Blair A, Jonas W, Lillieskold S, Svensson K, Ahmed AH, Bastarache LR, Crenshaw JT, Giugliani ERJ, Grady JE, Zakarija-Grkovic I, Haider R, Hill RR, Kagawa MN, Mbalinda SN, Stevens J, Takahashi Y, Cadwell K. Immediate or early skin-to-skin contact for mothers and their healthy newborn infants. Cochrane Database Syst Rev. 2025 Oct 22;10(10):CD003519. doi: 10.1002/14651858.CD003519.pub5. PubMed 41120189 ↗
  • Huang Y, Chen L, Wang X, Zhao C, Guo Z, Li J, Yang F, Cai W. Maternal knowledge, attitudes and practices related to neonatal jaundice and associated factors in Shenzhen, China: a facility-based cross-sectional study. BMJ Open. 2022 Aug 24;12(8):e057981. doi: 10.1136/bmjopen-2021-057981. PubMed 36002214 ↗
  • Zarei Salehabadei M, Amini L, Haghani S, Sadeghi Avval Shahr H. Postpartum depression and paternal-infant attachment in Iranian fathers. J Reprod Infant Psychol. 2025 Mar 27:1-14. doi: 10.1080/02646838.2025.2485120. Online ahead of print. PubMed 40150891 ↗
  • Karaman SC, Unal E, Demir H. Investigation of the effect of fathers' postnatal feelings of security on father-infant attachment. J Pediatr Nurs. 2025 Nov-Dec;85:586-592. doi: 10.1016/j.pedn.2025.09.022. Epub 2025 Sep 27. PubMed 41016224 ↗

Related links

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2026; primary completion for Jun 2026, 3 months later.

Of 505 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 3 months is below that.

Counting every sponsor, half of 513 studies reached it within 12 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 8, 2026
First posted
Feb 13, 2026
StartEst.
Mar 2026
Primary completionEst.
Jun 2026
CompletionEst.
Jul 2026
Last update
Feb 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07410754
Responsible party
Paria Mohammadiasl (Paria MOHAMMADİASL, Istanbul University - Cerrahpasa) — Principal investigator
First posted
Feb 13, 2026
Start date
Mar 2026 (estimated)
Primary completion
Jun 2026 (estimated)
Completion
Jul 2026 (estimated)
Last update
Feb 13, 2026

Study contacts

Paria Study Coordinator / Midwife, MSc
Contact
paria.mohammadiasl@ogr.iuc.edu.tr
+905526018494
Sevil Professor/Advisor, PhD
Contact
sevil@iuc.edu.tr
+90 212 866 3700 ext. 43162
sevil İnal, PhD
study chair · Cerrahpaşa University, Faculty of Health Sciences, Midwifery Department
Paria Mohammadiasl, MSc
principal investigator · Zeytinburu Avrasya Hospital / Cerrahpaşa University, Midwifery Department

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion